デフォルト表紙
市場調査レポート
商品コード
1629204

前臨床用フルイディクスの世界市場:製品別・用途別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年~2032年)

Fluidics for Preclinical Market, By Product, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032


出版日
ページ情報
英文 284 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
前臨床用フルイディクスの世界市場:製品別・用途別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年~2032年)
出版日: 2024年11月02日
発行: AnalystView Market Insights
ページ情報: 英文 284 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

前臨床用フルイディクスの市場規模は2023年に41億2,043万米ドルとなり、2024年から2032年にかけてCAGR 6.33%で拡大

前臨床用フルイディクスの市場力学

マイクロ流体技術の進歩、創薬、費用対効果の向上が市場需要を促進する見込み

前臨床用フルイディクス市場は、バイオテクノロジーの進歩、効率的な創薬手法への需要の高まりによって急成長しています。最近のマイクロ流体工学の技術革新は前臨床研究に革命をもたらし、高度なラボオンチップシステムや臓器オンチッププラットフォームの開発を可能にしています。これらの装置は、流体の流れを精密に制御し、生理的条件を模倣することができるため、複雑な生物学的プロセスを研究するのに不可欠なツールとなっています。人間のような環境をシミュレートする能力は、従来の2次元細胞培養や動物実験よりも正確なモデルを研究者に提供します。製薬業界やバイオテクノロジー業界は、医薬品開発の時間とコストを削減しなければならないというプレッシャーに直面しています。フルイディクスベースシステムは、ハイスループット・スクリーニング機能を提供し、制御された条件下で何千もの薬剤候補の迅速な試験を可能にします。これにより、初期段階の研究が加速されるとともに、臨床結果の予測が改善されます。

フルイディクスベース技術は、従来の方法と比較して、より少ないサンプル量、より少ない試薬、より少ない労力で済むため、コスト効率が高いです。これは、研究予算が限られている中小企業 (SME) や学術機関にとって特に有利です。さらに、これらのシステムのスケーラビリティは、創薬におけるハイスループットアプリケーションをサポートします。フルイディクスとAI、3Dプリンティング、バイオインフォマティクスの統合は、その応用を拡大しつつあります。学界、産業界、政府間の協力体制は、フルイディクスをベースとした新しい前臨床ツールの開発を加速し、市場の成長を後押ししています。

前臨床用フルイディクス市場:主な考察

弊社のリサーチアナリストの分析によると、世界市場は予測期間 (2024-2032年) に約6.33%のCAGRで毎年成長すると予測されています。

製品別に見ると、AIとビッグデータ分析におけるソフトウェアソリューションの採用増加により、ソフトウェア・付属品セグメントが2023年に最大市場シェアを示すと予測されました。

用途別に見ると、mRNAワクチン、免疫測定技術などの需要の高まりにより、臨床セグメントが2023年に主要用途となりました。

エンドユーザー別に見ると、感染症の高い流行により、病院セグメントが2023年の主要エンドユーザーセグメントでした。

地域別では、医療インフラが確立されている北米が2023年の主要収益源でした。

前臨床用フルイディクス市場:セグメンテーション分析

前臨床用フルイディクスの世界市場は、製品、用途、エンドユーザー、地域に基づいて区分されます。

製品は精密シリンジポンプとソフトウェア・付属品の2つに分類されます。ソフトウェア&サービス分野が市場を独占しています。マイクロ流体キットの技術進歩が進んでいることが、このセグメントの需要に寄与しています。

市場は用途別に臨床、生命科学研究、その他の3つに分類されます。予測期間中、臨床分野が優位を占めると予測されています。生命科学研究分野は、新薬の前臨床研究への投資の増加により、最も速い速度で成長すると推定されます。

市場はエンドユーザー別に病院、クリニック、その他の3つに分類されます。病院セグメントが市場を独占しており、予測期間中も高い優位性を維持すると予想されます。心血管、糖尿病などの慢性疾患の有病率の増加や、ポイントオブケア検査の需要が高まっています。

前臨床用フルイディクス市場:地域別分析

前臨床用フルイディクス市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの各地域に広がっています。北米が前臨床用フルイディクス市場を独占しているのは、主に研究機関や学術プロジェクトに対する政府および民間の強力な資金提供によるものです。米国は年間の臨床試験件数と新薬承認件数でリードしています。欧州では、EUのREACH規制など、動物実験を制限する厳しい法律があります。ドイツ、英国、フランスなどの国々では、学術的・研究的な取り組みが盛んです。アジア太平洋は、特に中国とインドで生命科学研究に対する政府投資が増加しており、最も急成長している地域です。

前臨床用フルイディクス市場:競合情勢

前臨床用フルイディクス市場は競争が激しく、多数の企業が前臨床研究の需要増に対応するための技術革新に注力しています。主要企業は積極的に製品ポートフォリオを強化し、市場でのプレゼンスを拡大しています。前臨床研究では、マイクロ流体技術や臓器オンチップ技術の進歩が極めて重要です。これらの技術革新は、流体の流れを正確に制御し、生理学的条件を模倣することで、前臨床モデルの精度を高めます。Opentrons社やEmulate社などの主要企業が技術的進歩をリードしています。革新的な製品のイントロダクションと新興市場への進出が、今後数年間の大幅な成長の原動力になると予想されます。

目次

第1章 前臨床用フルイディクス市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 前臨床用フルイディクスの主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 前臨床用フルイディクス市場:産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し:マッピング
  • 規制体制の分析

第5章 前臨床用フルイディクス市場:COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 前臨床用フルイディクスの市場情勢

  • 前臨床用フルイディクスの市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 前臨床用フルイディクス市場:製品別

  • 概要
    • セグメント別シェア分析:製品別
    • 精密シリンジポンプ
    • ソフトウェア・付属品

第8章 前臨床用フルイディクス市場:用途別

  • 概要
    • セグメント別シェア分析:用途別
    • 臨床
    • 生命科学研究
    • その他

第9章 前臨床用フルイディクス市場:エンドユーザー別

  • 概要
    • セグメント別シェア分析:エンドユーザー別
    • 病院
    • クリニック
    • その他

第10章 前臨床用フルイディクス市場:地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋 (APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析:前臨床用フルイディクス業界

  • 競争ダッシュボード
  • 企業プロファイル
    • Danaher Corporation
    • Thermo Fisher Scientific
    • Emulate, Inc.
    • Opentrons Labworks
    • Dolomite Microfluidics
    • PerkinElmer, Inc.
    • Illumina, Inc.
    • Agilent Technologies
    • Fluidigm Corporation
    • Bio-Rad Laboratories
    • Tecan Group Ltd.
    • CN Bio Innovations
    • Mimetas BV
    • Axion BioSystems
    • Roche Diagnostics
    • Others

第12章 AnalystViewの全方位的分析

目次
Product Code: ANV4361

REPORT HIGHLIGHT

Fluidics for Preclinical Market size was valued at USD 4,120.43 Million in 2023, expanding at a CAGR of 6.33% from 2024 to 2032.

Fluidics for preclinical applications involves the use of fluidic systems, such as microfluidic devices or engineered fluid flows, to study biological, chemical, or pharmaceutical processes in the early stages of medical research. These systems are highly relevant in preclinical research for testing new drugs, studying disease mechanisms, or exploring the behavior of cells and biomolecules in controlled environments.

Fluidics for Preclinical Market- Market Dynamics

Growing advancement in microfluidic technology, drug discoveries and cost-effectiveness benefits are expected to propel market demand

The fluidics for preclinical market is growing rapidly, driven by advancements in biotechnology, increasing demand for efficient drug discovery methods. Recent innovations in microfluidics have revolutionized preclinical research, enabling the development of sophisticated lab-on-a-chip systems and organ-on-chip platforms. These devices allow precise control over fluid flows and mimic physiological conditions, making them indispensable tools for studying complex biological processes. Their ability to simulate human-like environments provides researchers with more accurate models than traditional 2D cell cultures or animal testing. The pharmaceutical and biotechnology industries face mounting pressure to reduce the time and cost of drug development. Fluidics-based systems provide high-throughput screening capabilities, enabling rapid testing of thousands of drug candidates under controlled conditions. This accelerates early-stage research while improving the prediction of clinical outcomes.

Fluidics-based technologies are cost-effective compared to traditional methods, requiring smaller sample volumes, fewer reagents, and less labor. This is particularly advantageous for small and medium-sized enterprises (SMEs) and academic institutions that may have limited research budgets. Furthermore, the scalability of these systems supports high-throughput applications in drug discovery. The integration of fluidics with AI, 3D printing, and bioinformatics is expanding its applications. Collaborative efforts between academia, industry, and government are accelerating the development of novel fluidics-based preclinical tools, boosting market growth.

Fluidics for Preclinical Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.33% over the forecast period (2024-2032)

Based on Product segmentation, software & accessories segment was predicted to show maximum market share in the year 2023, owing to increasing adoption of software solutions in AI and big data analytics.

Based on Application segmentation, clinical segment was the leading application in 2023, due to rising demand for mRNA vaccines, immunoassay techniques, etc.

Based on End User segmentation, hospitals segment was the leading End User segment in 2023, due to high prevalence of infectious diseases.

On the basis of region, North America was the leading revenue generator in 2023, owing to presence of established healthcare infrastructure.

Fluidics for Preclinical Market- Segmentation Analysis:

The Global Fluidics for Preclinical Market is segmented on the basis of Product, Application, End User, and Region.

The market is divided into two categories based on Product: precision syringe pumps and software & accessories. The software & services segment dominates the market. The growing tech advancements in microfluidic kits are contributing to segment demand.

The market is divided into three categories based on the Application: clinical, life science research, and others. The clinical segment is expected to dominate over the forecast period. Life science research segment is estimated to grow at fastest rate owing to increasing investment in preclinical research for novel drugs.

The market is divided into three categories based on End User: hospitals, clinics, and others. The hospitals segment dominates the market and is expected to maintain its high dominance during the forecast period. The increasing prevalence of chronic disorders such as cardiovascular, diabetes and the demand for point of care testing.

Fluidics for Preclinical Market- Geographical Insights

Worldwide, the Fluidics for Preclinical market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America dominates the Fluidics for Preclinical market, primarily due to the strong government and private funding for research institutions and academic projects. The U.S. leads in the number of clinical trials and new drug approvals annually. In Europe, stringent laws restricting animal testing, such as the European Union's REACH regulations. Strong academic and research initiatives in countries like Germany, the UK, and France. Asia Pacific is the fastest growing region with the increasing government investments in life sciences research, particularly in China and India.

Fluidics for Preclinical Market- Competitive Landscape:

The Fluidics for Preclinical Market is highly competitive, with numerous players focusing on innovations to cater to the increasing demand in preclinical research. Key players are actively enhancing their product portfolios and expanding their market presence. Advancements in microfluidics and organ-on-chip technologies are pivotal in preclinical research. These innovations offer precise control over fluid flows and mimic physiological conditions, enhancing the accuracy of preclinical models. Companies like Opentrons and Emulate leading technological advancements. The introduction of innovative products and the expansion into emerging markets are expected to drive substantial growth in the coming years.

Recent Developments:

In 2024, Opentrons introduced the Flex Prep, a no-code robot offering simplicity akin to a pipette with the versatility of a liquid handler.

In 2023, Opentrons launched the Flex lab robot, designed to democratize lab automation with an open-source API, facilitating integration with AI tools.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL FLUIDICS FOR PRECLINICAL MARKET KEY PLAYERS

  • Danaher Corporation
  • Thermo Fisher Scientific
  • Emulate, Inc.
  • Opentrons Labworks
  • Dolomite Microfluidics
  • PerkinElmer, Inc.
  • Illumina, Inc.
  • Agilent Technologies
  • Fluidigm Corporation
  • Bio-Rad Laboratories
  • Tecan Group Ltd.
  • CN Bio Innovations
  • Mimetas BV
  • Axion BioSystems
  • Roche Diagnostics
  • Others

GLOBAL FLUIDICS FOR PRECLINICAL MARKET, BY PRODUCT- MARKET ANALYSIS, 2019-2032

  • Precision syringe pumps
  • Software & accessories

GLOBAL FLUIDICS FOR PRECLINICAL MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Clinical
  • Life Science Research
  • Others

GLOBAL FLUIDICS FOR PRECLINICAL MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospital
  • Clinics
  • Others

GLOBAL FLUIDICS FOR PRECLINICAL MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Fluidics for Preclinical Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Fluidics for Preclinical Market Snippet by Product
    • 2.1.2. Fluidics for Preclinical Market Snippet by Application
    • 2.1.3. Fluidics for Preclinical Market Snippet by End User
    • 2.1.4. Fluidics for Preclinical Market Snippet by Country
    • 2.1.5. Fluidics for Preclinical Market Snippet by Region
  • 2.2. Competitive Insights

3. Fluidics for Preclinical Key Market Trends

  • 3.1. Fluidics for Preclinical Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Fluidics for Preclinical Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Fluidics for Preclinical Market Opportunities
  • 3.4. Fluidics for Preclinical Market Future Trends

4. Fluidics for Preclinical Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Fluidics for Preclinical Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Fluidics for Preclinical Market Landscape

  • 6.1. Fluidics for Preclinical Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Fluidics for Preclinical Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Precision syringe pumps
    • 7.1.3. Software & accessories

8. Fluidics for Preclinical Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Clinical
    • 8.1.3. Life Science Research
    • 8.1.4. Others

9. Fluidics for Preclinical Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospital
    • 9.1.3. Clinics
    • 9.1.4. Others

10. Fluidics for Preclinical Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Fluidics for Preclinical Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Fluidics for Preclinical Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Fluidics for Preclinical Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Fluidics for Preclinical Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Fluidics for Preclinical Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Fluidics for Preclinical Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Danaher Corporation
    • 11.2.2. Thermo Fisher Scientific
    • 11.2.3. Emulate, Inc.
    • 11.2.4. Opentrons Labworks
    • 11.2.5. Dolomite Microfluidics
    • 11.2.6. PerkinElmer, Inc.
    • 11.2.7. Illumina, Inc.
    • 11.2.8. Agilent Technologies
    • 11.2.9. Fluidigm Corporation
    • 11.2.10. Bio-Rad Laboratories
    • 11.2.11. Tecan Group Ltd.
    • 11.2.12. CN Bio Innovations
    • 11.2.13. Mimetas BV
    • 11.2.14. Axion BioSystems
    • 11.2.15. Roche Diagnostics
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us